InvestorsHub Logo
Followers 43
Posts 9124
Boards Moderated 0
Alias Born 01/06/2011

Re: MateoPaisa post# 233794

Saturday, 12/14/2019 5:08:21 PM

Saturday, December 14, 2019 5:08:21 PM

Post# of 427141
To make a long story short. Abbreviated explanation;

The main reason for no competition, patent infringement. Marketing came to a halt after AZN withdrew and does not market the drug. This decision was made during the patent infringement case filed by Amarin. I believe they where ordered to notify Amarin before attempting to market Epanova.
Hasn’t been prescribed to a single patient.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News